Small molecules that modulate PKM2 activity to resemble PKM1 can change the metabolic profile of cancer cells in culture and inhibit growth of tumors in vivo, demonstrating the potential utility of isoform-specific therapies (9). This evidence concerns the gene PKM and cancer.